Fig. 3From: Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in UgandaDrug resistance mutation profiles among subtypes. **Significant difference across HIV-1 subtypesBack to article page